Catalyst Wire Dossier Catalyst Wire Dossier

PresbiDrops

CSF-1 · Orasis Pharmaceuticals Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PresbiDrops, covering 2017-08-01 to 2017-08-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Efficacy of PresbiDrops (CSF-1) in Presbyopic Subjects [Phase 2]

See pricing